Zoetis (ZTS) Cash & Equivalents (2012 - 2026)

Zoetis (ZTS) has 15 years of Cash & Equivalents data on file, last reported at $1.9 billion in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 12.78% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 12.78% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 23.3% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.9 billion, down from $2.4 billion in the prior quarter.
• Over the last five years, Cash & Equivalents for ZTS reached as high as $3.6 billion in Q4 2022 and fell as low as $1.4 billion in Q2 2025.
• Historically, Cash & Equivalents has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2024.
• Across the five-year window, Cash & Equivalents tumbled 43.0% in 2023 and climbed 23.3% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $3.6 billion in 2022, then tumbled by 43.0% to $2.0 billion in 2023, then slipped by 2.65% to $2.0 billion in 2024, then increased by 23.3% to $2.4 billion in 2025, then fell by 20.78% to $1.9 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $1.9 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.1 billion in Q3 2025.